Ladenburg Thalmann Financial Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $6K | Buy |
117
+29
| +33% | +$1.49K | ﹤0.01% | 4732 |
|
2019
Q3 | $4K | Hold |
88
| – | – | ﹤0.01% | 4808 |
|
2019
Q2 | $8K | Buy |
88
+28
| +47% | +$2.55K | ﹤0.01% | 4556 |
|
2019
Q1 | $9K | Hold |
60
| – | – | ﹤0.01% | 4441 |
|
2018
Q4 | $9K | Hold |
60
| – | – | ﹤0.01% | 4359 |
|
2018
Q3 | $15K | Buy |
60
+23
| +62% | +$5.75K | ﹤0.01% | 4078 |
|
2018
Q2 | $9K | Hold |
37
| – | – | ﹤0.01% | 4326 |
|
2018
Q1 | $9K | Buy |
37
+31
| +517% | +$7.54K | ﹤0.01% | 4326 |
|
2017
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 4815 |
|
2017
Q3 | $2K | Buy |
6
+1
| +20% | +$333 | ﹤0.01% | 4710 |
|
2017
Q2 | $2K | Hold |
5
| – | – | ﹤0.01% | 4635 |
|
2017
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 4763 |
|
2016
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 4732 |
|